Compliance Policy for Combination Product Postmarketing Safety Reporting: Immediately in Effect Guidance for Industry and Food and Drug Administration Staff
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Combination Products
Published
April 20, 2019
Last updated
May 7, 2020
Description
This document is a guidance document titled "Compliance Policy for Combination Product Postmarketing Safety Reporting" for industry and FDA staff.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)